Carmot Therapeutics' Grant - III Round

Carmot Therapeutics raised a round of funding on July 13, 2011. Investors include National Institute of Diabetes and Digestive and Kidney Diseases.

Carmot Therapeutics is applying its technology, Chemotype Evolution, to address unmet chemical needs in drug discovery, focusing on high-profile targets for which drug leads have been difficult to ide…

Articles about Carmot Therapeutics' Grant - III Round: